BioSpace News Archive

Memory Health LLC announced today that the United Kingdom Patent Office has issued a patent, related to the company’s uniquely-formulated Memory Health brain health supplement, for “the prevention and/or treatment of neurodegenerative disease.” “This is a major milestone in the endless quest to prevent and treat neurodegene

Survival outcomes for HPV-positive oropharyngeal squamous cell carcinoma of the head and neck (SCCHN) have made significant gains in recent years, but new research in the February 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds some groups are being left behind.

LogixHealth has released its 2020 Emergency Department Physician Update, a comprehensive review of Medicare’s 2020 Physician Fee Schedule Final Rule.

SAN DIEGO, Feb. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced the pricing of an underwritten public offering of 4,235,294 shares of its common stock at a price to the public of $4.25 per share. The offering is expected to close on or about February 10, 2020, subject to customary closing conditions. aTyr has also granted the underwrit

Kineticos announced today the Kineticos Disruptor Fund , a new life sciences investment fund. The fund will invest in disruptive modalities including cell therapy approches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.

Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that it has entered into definitive agreements with institutional investors to purchase an aggregate of up to 7,500,000 shares

As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson

Belong.Life, creator of the Belong - Beating Cancer Together mobile app, will share a study tomorrow at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando showing that cancer patients who had discussions with their doctors about the financial challenges of receiving immunotherapy before beginning treatment were 37.5% more likely to avoid financial toxicity when receiving cancer immunotherapy treatments.

The clinical trials initiated in the United States and in Israel will evaluate safety, tolerability and efficacy of PrimeC, NeuroSense’s product for ALS patients.